StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Vita 34 AG
XETRA:V3V.DE
Sector
Industries
Location
Market Cap
USD 99.02 M
Share Price
USD 5.68
Avg Daily Volume
2,315
Change (1 day)
-0.10%
Change (1 year)
17.72%
Change (YTD)
32.49%
Vita 34 AG Operating Cash Flow for the year ending December 31, 2024: USD 8.96 M
Vita 34 AG Operating Cash Flow is USD 8.96 M for the year ending December 31, 2024, a -11.30% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Vita 34 AG Operating Cash Flow for the year ending December 31, 2023 was USD 10.10 M, a -310.51% change year over year.
-
Vita 34 AG Operating Cash Flow for the year ending December 31, 2022 was USD -4.80 M, a -254.62% change year over year.
-
Vita 34 AG Operating Cash Flow for the year ending December 31, 2021 was USD 3.10 M, a -36.15% change year over year.
-
Vita 34 AG Operating Cash Flow for the year ending December 31, 2020 was USD 4.86 M, a -31.43% change year over year.
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Danaher Corporation
USD 204.85
DHR
-0.66
-0.32%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%
Zoetis Inc.
USD 154.96
ZTS
-3.84
-2.42%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Boston Scientific Corporation
USD 103.20
BSX
-0.66
-0.64%
Danaher Corporation
USD 204.85
DHR
-0.66
-0.32%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.36
4519.T
-0.52
-1.11%
CSL Limited
USD 158.31
CSL.AX
-1.36
-0.85%
Zoetis Inc.
USD 154.96
ZTS
-3.84
-2.42%